Elon Musk’s Brain Implant Company Is Inching Toward Human Trials

108
11
Favorite

Elon Musk’s Brain Implant Company Is Inching Toward Human Trials

Bloomberg2022-01-20

Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

108

Report

Comment（11）

ZEROHERO
·2022-01-21
Hello Cyborgs 🤖
Reply
1
Report
KLC
·2022-01-21
Tell me your opinion about this news...
Reply
1
Report
Ah Deck
·2022-01-21
What is in Rlin’s mind !??😱😱😱
Reply
Like
Report
Barbarazhao
·2022-01-21
Interesting
Reply
1
Report
Nelsonon
·2022-01-21
Wow
Reply
2
Report
HF133
·2022-01-21
Ok
Reply
1
Report
PC21
·2022-01-20
Matrix?
Reply
1
Report
MoneyCentral
·2022-01-20
Scary thought
Reply
2
Report
我已经戒赌股票了相信我
·2022-01-20
Ok
Reply
1
Report
zeeling
·2022-01-20
Great
Reply
2
Report
JiaDeName
·2022-01-20
Like pls thx
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1108899147?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-20 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108899147","market":"us","top_or_hot":-1,"title":"Elon Musk’s Brain Implant Company Is Inching Toward Human Trials","media":"Bloomberg","content":"<div>\n<p>Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk’s Brain Implant Company Is Inching Toward Human Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk’s Brain Implant Company Is Inching Toward Human Trials\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 22:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TSLA","symbol_name":"特斯拉","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials","article_id":"1108899147","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108899147","pubTimestamp":1642690690,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographe","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TSLA":"特斯拉"},"translate_title":"埃隆·马斯克的大脑植入公司正慢慢走向人体试验","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TSLA":0.9},"content_text":"Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial director, an indication that the company’s longstanding goal of implanting chips in human brains is coming closer.The trial director position would oversee the startup’s long-promised human trials of its medical device, according to the listing. Neuralink’s brain implant — which Musk has said already allows monkeys to play video games with their thoughts alone — is intended to help treat a variety of neurological disorders, such as paralysis.The job description for the position, based in Fremont, California, promises that the applicant will “work closely with some of the most innovative doctors and top engineers” as well as with “Neuralink’s first Clinical Trial participants.” It also indicates that the job will mean leading and building “the team responsible for enabling Neuralink’s clinical research activities,” as well as adhering to regulations.Last month, Musk told the Wall Street Journal that Neuralink hoped to implant its device in human brains sometime in 2022. However, he has made similar predictions in the past that proved overly optimistic — including in 2019, when he said during apresentationthat the device would be in human skulls by the following year.The first in-human test that medical device makers must go through on the path to U.S. Food and Drug Administration approval is known as a feasibility test. The next, after a submission, review and approval process with the FDA based on the feasibility test, is a pivotal device test.It isn’t clear precisely where Neuralink is in the process. Representatives for Neuralink and the FDA didn’t respond to requests for comment. Generally, device makers hire trial directors early in their interaction with the FDA, to help design trials in a way that would maximize the chances of FDA approval. Neuralink doesn’t appear to have human trials posted on clinicaltrials.gov, but postings there can lag recruitment of the first patients.Last year, another company working on brain-machine interfaces, Synchron, said the FDA had approved its planned feasibility study. Synchron is currently in the recruiting stage, a spokeswoman said.Neuralink is also advertising for a Fremont-based clinical trial coordinator, as well as several other positions.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9007960709,"gmtCreate":1642738244213,"gmtModify":1676533742158,"author":{"id":"3566532164444643","authorId":"3566532164444643","name":"ZEROHERO","avatar":"https://static.tigerbbs.com/62813b6df1c4722e559d112fadd5486a","vip":2,"crmLevel":8,"crmLevelSwitch":1,"idStr":"3566532164444643","authorIdStr":"3566532164444643"},"htmlText":"Hello&nbsp;Cyborgs 🤖","listText":"Hello&nbsp;Cyborgs 🤖","text":"Hello Cyborgs 🤖","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007960709","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9007086068,"gmtCreate":1642722089106,"gmtModify":1676533739249,"author":{"id":"3567916089112278","authorId":"3567916089112278","name":"KLC","avatar":"https://static.tigerbbs.com/7b5f29591734279d9235e132e16aa719","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3567916089112278","authorIdStr":"3567916089112278"},"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007086068","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9007088838,"gmtCreate":1642721988858,"gmtModify":1676533739233,"author":{"id":"4098445225447010","authorId":"4098445225447010","name":"Ah Deck","avatar":"https://static.tigerbbs.com/0e52eb1e14e0f630d24f1687ea546cd8","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"4098445225447010","authorIdStr":"4098445225447010"},"htmlText":"What is in Rlin’s mind !??😱😱😱","listText":"What is in Rlin’s mind !??😱😱😱","text":"What is in Rlin’s mind !??😱😱😱","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007088838","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9007089742,"gmtCreate":1642721674890,"gmtModify":1676533739173,"author":{"id":"3576888762442253","authorId":"3576888762442253","name":"Barbarazhao","avatar":"https://static.tigerbbs.com/40f6fdeabe0e8cac300f1fd2a17eb3ac","vip":1,"crmLevel":8,"crmLevelSwitch":1,"idStr":"3576888762442253","authorIdStr":"3576888762442253"},"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007089742","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004778184,"gmtCreate":1642715296203,"gmtModify":1676533737775,"author":{"id":"3563004462019636","authorId":"3563004462019636","name":"Nelsonon","avatar":"https://static.tigerbbs.com/82a053e6a2ff694debc9f499cdc75ec6","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3563004462019636","authorIdStr":"3563004462019636"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004778184","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004770850,"gmtCreate":1642713999369,"gmtModify":1676533737681,"author":{"id":"3583621807888930","authorId":"3583621807888930","name":"HF133","avatar":"https://static.tigerbbs.com/ce211305e06a021e08ecfcbc0e23bbb5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583621807888930","authorIdStr":"3583621807888930"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004770850","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004761656,"gmtCreate":1642692585099,"gmtModify":1676533736493,"author":{"id":"4087611507686430","authorId":"4087611507686430","name":"PC21","avatar":"https://static.tigerbbs.com/a62d208e3b3c4a550849feaa8117655b","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4087611507686430","authorIdStr":"4087611507686430"},"htmlText":"Matrix?","listText":"Matrix?","text":"Matrix?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004761656","repostId":1108899147,"repostType":4,"repost":{"id":"1108899147","kind":"news","pubTimestamp":1642690690,"share":"https://ttm.financial/m/news/1108899147?lang=&edition=fundamental","pubTime":"2022-01-20 22:58","market":"us","language":"en","title":"Elon Musk’s Brain Implant Company Is Inching Toward Human Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1108899147","media":"Bloomberg","summary":"Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographe","content":"<html><head></head><body><p>Neuralink has posted job listings for a clinical trial director and coordinator.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3d190d89621258d6a0356ee3117e10f6\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>Elon MuskPhotographer: Andrew Harrer/Bloomberg</span></p><p>Elon Musk’s brain implant company Neuralink is now hiring a clinical trial director, an indication that the company’s longstanding goal of implanting chips in human brains is coming closer.</p><p>The trial director position would oversee the startup’s long-promised human trials of its medical device, according to the listing. Neuralink’s brain implant — which Musk has said already allows monkeys to play video games with their thoughts alone — is intended to help treat a variety of neurological disorders, such as paralysis.</p><p>The job description for the position, based in Fremont, California, promises that the applicant will “work closely with some of the most innovative doctors and top engineers” as well as with “Neuralink’s first Clinical Trial participants.” It also indicates that the job will mean leading and building “the team responsible for enabling Neuralink’s clinical research activities,” as well as adhering to regulations.</p><p>Last month, Musk told the Wall Street Journal that Neuralink hoped to implant its device in human brains sometime in 2022. However, he has made similar predictions in the past that proved overly optimistic — including in 2019, when he said during apresentationthat the device would be in human skulls by the following year.</p><p>The first in-human test that medical device makers must go through on the path to U.S. Food and Drug Administration approval is known as a feasibility test. The next, after a submission, review and approval process with the FDA based on the feasibility test, is a pivotal device test.</p><p>It isn’t clear precisely where Neuralink is in the process. Representatives for Neuralink and the FDA didn’t respond to requests for comment. Generally, device makers hire trial directors early in their interaction with the FDA, to help design trials in a way that would maximize the chances of FDA approval. Neuralink doesn’t appear to have human trials posted on clinicaltrials.gov, but postings there can lag recruitment of the first patients.</p><p>Last year, another company working on brain-machine interfaces, Synchron, said the FDA had approved its planned feasibility study. Synchron is currently in the recruiting stage, a spokeswoman said.</p><p>Neuralink is also advertising for a Fremont-based clinical trial coordinator, as well as several other positions.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk’s Brain Implant Company Is Inching Toward Human Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk’s Brain Implant Company Is Inching Toward Human Trials\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-20 22:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.bloomberg.com/news/articles/2022-01-20/elon-musk-s-brain-implant-company-is-inching-toward-human-trials","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108899147","content_text":"Neuralink has posted job listings for a clinical trial director and coordinator.Elon MuskPhotographer: Andrew Harrer/BloombergElon Musk’s brain implant company Neuralink is now hiring a clinical trial director, an indication that the company’s longstanding goal of implanting chips in human brains is coming closer.The trial director position would oversee the startup’s long-promised human trials of its medical device, according to the listing. Neuralink’s brain implant — which Musk has said already allows monkeys to play video games with their thoughts alone — is intended to help treat a variety of neurological disorders, such as paralysis.The job description for the position, based in Fremont, California, promises that the applicant will “work closely with some of the most innovative doctors and top engineers” as well as with “Neuralink’s first Clinical Trial participants.” It also indicates that the job will mean leading and building “the team responsible for enabling Neuralink’s clinical research activities,” as well as adhering to regulations.Last month, Musk told the Wall Street Journal that Neuralink hoped to implant its device in human brains sometime in 2022. However, he has made similar predictions in the past that proved overly optimistic — including in 2019, when he said during apresentationthat the device would be in human skulls by the following year.The first in-human test that medical device makers must go through on the path to U.S. Food and Drug Administration approval is known as a feasibility test. The next, after a submission, review and approval process with the FDA based on the feasibility test, is a pivotal device test.It isn’t clear precisely where Neuralink is in the process. Representatives for Neuralink and the FDA didn’t respond to requests for comment. Generally, device makers hire trial directors early in their interaction with the FDA, to help design trials in a way that would maximize the chances of FDA approval. Neuralink doesn’t appear to have human trials posted on clinicaltrials.gov, but postings there can lag recruitment of the first patients.Last year, another company working on brain-machine interfaces, Synchron, said the FDA had approved its planned feasibility study. Synchron is currently in the recruiting stage, a spokeswoman said.Neuralink is also advertising for a Fremont-based clinical trial coordinator, as well as several other positions.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004769532,"gmtCreate":1642692245681,"gmtModify":1676533736448,"author":{"id":"4091678983335410","authorId":"4091678983335410","name":"MoneyCentral","avatar":"https://static.tigerbbs.com/b65487e9bb510d46c3ac12f7427011cb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4091678983335410","authorIdStr":"4091678983335410"},"htmlText":"Scary thought","listText":"Scary thought","text":"Scary thought","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004769532","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004786541,"gmtCreate":1642691429393,"gmtModify":1676533736300,"author":{"id":"3571736667951592","authorId":"3571736667951592","name":"我已经戒赌股票了相信我","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571736667951592","authorIdStr":"3571736667951592"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004786541","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004781902,"gmtCreate":1642691197857,"gmtModify":1676533736272,"author":{"id":"3578196134540225","authorId":"3578196134540225","name":"zeeling","avatar":"https://static.tigerbbs.com/901d745faf2cd5225a6dbed44ad6236a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578196134540225","authorIdStr":"3578196134540225"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004781902","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004789424,"gmtCreate":1642691082586,"gmtModify":1676533736205,"author":{"id":"4098932726636920","authorId":"4098932726636920","name":"JiaDeName","avatar":"https://static.tigerbbs.com/ac12c2e59cfb8844340b865b07eb5648","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4098932726636920","authorIdStr":"4098932726636920"},"htmlText":"Like pls thx","listText":"Like pls thx","text":"Like pls thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004789424","repostId":1108899147,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":108,"commentSize":11,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}